Ophthalmology is one of the most actively traded specialties in healthcare M&A. The combination of demographic tailwinds (aging population needing cataract surgery), procedural revenue streams (LASIK, premium IOLs), and fragmented market structure makes eye care an irresistible target for private equity consolidation.
Whether you're running a comprehensive ophthalmology practice, a subspecialty retina or glaucoma clinic, or a LASIK center, understanding the current buyer landscape is essential for maximizing your exit value.
2026 Eye Care Multiples
Ophthalmology practices are selling at 5.5x - 8.5x EBITDA, with premium practices (multi-location, high surgical volume, strong subspecialty mix) commanding the upper end. Practices with established ASC ownership or joint ventures can see multiples above 9x when the surgery center economics are included.
Why Ophthalmology Attracts Premium Valuations
Private equity interest in ophthalmology is driven by several factors that make eye care uniquely attractive for consolidation:
1. Demographic Tailwinds
The math is simple: cataract prevalence increases dramatically after age 60, and America is aging rapidly. The 65+ population will grow by 30% over the next decade, creating guaranteed demand growth for cataract surgery—the most commonly performed procedure in Medicare.
2. Multiple Revenue Streams
- Medical ophthalmology Glaucoma management, diabetic eye exams, dry eye treatment
- Cataract surgery High-volume, predictable, well-reimbursed
- Premium IOLs and astigmatism correction Cash-pay upgrades that improve margin
- Refractive surgery (LASIK/PRK) Pure elective, high margin when volume supports
- Retina/vitreoretinal High-acuity, specialized, excellent reimbursement
- Oculoplastics Cosmetic and reconstructive, often cash-pay
- Optical dispensary Ancillary revenue from frames and lenses
3. ASC Integration Opportunity
Eye care is ideally suited for ambulatory surgery center (ASC) ownership. Cataract surgery in an ASC generates significantly better margin than hospital outpatient settings. Many PE platforms specifically target practices with existing ASC ownership or JV opportunities, as the surgical economics drive platform profitability.
4. Scalable Operations
Unlike some specialties, ophthalmology can leverage optometrists and technicians effectively. A well-designed practice can see high patient volumes with appropriate staffing ratios, creating operating leverage that buyers value.
| Practice Profile | Typical Multiple | Key Value Drivers |
|---|---|---|
| Solo Comprehensive Ophthalmology | 4-6x EBITDA | Surgical volume, referral base, ASC access |
| Multi-MD Comprehensive Practice | 5.5-7.5x EBITDA | Scale, diversified subspecialties, management depth |
| Practice with ASC Ownership | 7-9x+ EBITDA | Surgery center economics, facility control |
| Subspecialty Retina Practice | 6-8x EBITDA | High-acuity cases, injection volume, referral network |
| LASIK/Refractive Center | 5-7x EBITDA | Volume, marketing efficiency, brand recognition |
Major Buyers in Eye Care M&A
The ophthalmology acquisition market is dominated by well-capitalized platform buyers:
PE-Backed Eye Care Platforms
Major players like EyeCare Partners, EyeSouth Partners, U.S. Vision Partners, and regional platforms are actively acquiring practices. These buyers typically offer:
- Highest valuations for practices that fit their geographic and strategic criteria
- Cash at close (60-80%) plus rollover equity (20-40%)
- Centralized administrative support (billing, HR, IT, marketing)
- Employment agreements (typically 3-5 years)
- Potential for significant "second bite" on platform exit
Health Systems
Hospital systems continue to build employed ophthalmology networks, particularly for surgical access and service line development. Health system deals typically feature:
- Moderate valuations (4-6x EBITDA)
- Strong employment benefits and security
- Hospital OR access and referral integration
- Less operational autonomy
Strategic Buyers (Larger Practices)
Some larger independent ophthalmology groups are expanding through acquisition before eventually selling to PE themselves. These deals can offer:
- Competitive multiples (5-7x)
- More collegial culture and clinical autonomy
- Partnership track for future equity participation
The ASC Premium
Practices with existing ASC ownership or dedicated surgical access routinely command 1-2x higher multiples than comparable practices without. If you're 3+ years from exit, investing in ASC development or partnership may dramatically increase your ultimate sale proceeds.
What Buyers Look For in Ophthalmology Practices
Premium Indicators
- High surgical volume 500+ cataracts/year per surgeon is attractive
- ASC ownership or JV Control of surgical economics is highly valued
- Multiple subspecialties Retina, glaucoma, cornea, oculoplastics
- Strong OD integration Optometrists expanding clinical capacity
- Premium IOL adoption High penetration of multifocal, toric, and extended depth lenses
- Modern equipment Current diagnostics, femtosecond laser availability
- Favorable payer mix Commercial insurance and Medicare Advantage
Value Detractors
- Solo practice Key-person risk limits valuation
- Hospital-dependent surgery No ASC access reduces margin
- 100% traditional Medicare No premium IOL revenue
- Aging equipment Capital needs reduce net proceeds
- High physician age Transition risk for 65+ sellers
Timeline for Selling an Ophthalmology Practice
| Phase | Duration | Key Activities |
|---|---|---|
| Pre-Sale Preparation | 12-24 months before | Optimize EBITDA, secure ASC economics, recruit associates |
| Advisor Engagement | 1-2 months | Select representation, develop marketing materials |
| Market Process | 2-4 months | Buyer outreach, NDAs, management presentations |
| LOI Negotiation | 2-4 weeks | Compare offers, negotiate price and terms |
| Due Diligence | 60-90 days | Financial review, credentialing, compliance, QofE |
| Definitive Documentation | 30-45 days | Purchase agreement, employment contracts, MSA |
| Closing | 1-2 weeks | Final signatures, wire transfer, transition begins |
What's Your Eye Care Practice Worth?
Our valuation calculator uses specialty-specific multiples to give you an instant estimate based on your revenue, EBITDA, and practice characteristics.
Request Confidential ValuationPreparing Your Ophthalmology Practice for Sale
Strategic preparation separates average exits from exceptional ones. Start positioning 18-24 months before going to market:
- Maximize surgical throughput Efficiency metrics matter to buyers
- Document premium IOL programs Track conversion rates and revenue per cataract
- Formalize OD relationships Employment or structured co-management agreements
- Clean up AR Reduce collection cycle, write off uncollectibles
- Lock in key staff Retention agreements for critical team members
- Extend facility lease 5+ years remaining at market rates
Next Steps
- Get a realistic valuation Understand what buyers will actually pay for your practice
- Assess your ASC position Ownership, JV, or opportunity to develop?
- Evaluate your timeline Are you ready now, or should you build value first?
- Consider your post-sale goals Maximum proceeds vs. optimal employment terms?
Start With Your Valuation
The first step in any exit is understanding your practice's market value. Get a confidential estimate in under a minute.
Calculate My Practice ValueRelated Resources
- Medical Practice Valuation Guide: Understanding EBITDA and multiples
- Selling to Private Equity: How PE deals work
- Healthcare Private Equity Firms: Major buyers in physician services
- ASC Valuation Guide: Surgery center economics and multiples